| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/30/1998 | WO1998017791A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 04/30/1998 | WO1998017784A1 Method for in vitro preconditioning of myoblasts before transplantation |
| 04/30/1998 | WO1998017783A1 Improved adenovirus vectors |
| 04/30/1998 | WO1998017779A1 NOVEL FabH |
| 04/30/1998 | WO1998017691A1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 04/30/1998 | WO1998017690A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | WO1998017687A2 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | WO1998017305A1 USE OF FasL OR FasL TRANSFECTED CD4+/FasL-/TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES |
| 04/30/1998 | WO1998017300A1 Mucin-mediated immunomodulation |
| 04/30/1998 | WO1998017116A1 Targeted cytotoxic cells |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | WO1998002562A3 Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides |
| 04/30/1998 | WO1998002545A3 Compositions and methods for plant pathogen resistance |
| 04/30/1998 | DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein |
| 04/30/1998 | DE19644500A1 AAV-DNA mit Helfervirus-Sequenzen AAV DNA having helper virus sequences |
| 04/30/1998 | CA2271721A1 Mini-e1a genes and gene products |
| 04/30/1998 | CA2270154A1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 04/30/1998 | CA2269755A1 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | CA2269656A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | CA2269507A1 Targeted cytotoxic cells |
| 04/30/1998 | CA2269349A1 Mucin-mediated immunomodulation |
| 04/30/1998 | CA2269123A1 Methods for generating and screening novel metabolic pathways |
| 04/30/1998 | CA2269121A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 04/30/1998 | CA2269034A1 Use of fasl or fasl transfected cd4+/fasl-/th1-cell lines for the treatment of th1/th2 diseases |
| 04/30/1998 | CA2269025A1 Pancreatic lipases and/or recombinant colipases and derived polypeptides produced by plants, methods for obtaining them and use thereof |
| 04/30/1998 | CA2268949A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 04/30/1998 | CA2268746A1 Placental-derived prostate growth factors |
| 04/30/1998 | CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | CA2268271A1 Lentiviral vectors |
| 04/30/1998 | CA2268016A1 Human eosinophil-derived basic protein |
| 04/30/1998 | CA2267636A1 Retroviral vectors |
| 04/30/1998 | CA2240843A1 Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same |
| 04/29/1998 | EP0838526A1 Human satellite microchromosomes as vectors for gene therapy |
| 04/29/1998 | EP0838522A2 Coccidiosis poultry vaccine |
| 04/29/1998 | EP0838148A2 A method of plant tissue culture and regeneration |
| 04/29/1998 | EP0838033A1 GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS |
| 04/29/1998 | EP0837944A2 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837936A1 New immunoregulatory protein lst-1 |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837933A1 Optimized minizymes and miniribozymes and uses thereof |
| 04/29/1998 | EP0837930A1 HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 04/29/1998 | EP0837927A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
| 04/29/1998 | EP0837926A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 04/29/1998 | EP0837880A2 Enamel matrix related polypeptide |
| 04/29/1998 | EP0837872A1 A cytotoxicity-based genetic selection system (toxsel) |
| 04/29/1998 | EP0837852A1 Pesticidal sulfur compounds |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0620847B1 Preparation of pure cultures of post-mitotic human neurons |
| 04/29/1998 | CN1180380A Expression of sucrose phosphorylase in plants |
| 04/29/1998 | CN1180377A Human embryonic lung fibroblast diploid cell strain suitable for production of virus and process for production of varicella zoster virus using same |
| 04/29/1998 | CN1180376A Cell line and process for multiplying rabies viruses and their quantitative detection |
| 04/29/1998 | CN1180375A Heterorhabditis bacteriophora insecticide compositions and related processes |
| 04/29/1998 | CN1180374A Method of preparing undifferentiated cell |
| 04/29/1998 | CN1180361A Cell growth substrate polymer |
| 04/29/1998 | CN1180107A Monoclonal antibody, cell line capable of producing monoclonal antibody and using monoclonal antibody |
| 04/29/1998 | CN1180105A Iris tissue culture media composition |
| 04/29/1998 | CN1180104A Iris tissue culture method |
| 04/28/1998 | US5744692 Nucleotide sequences coding an endopolygalacturonase inhibitor |
| 04/28/1998 | US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
| 04/28/1998 | US5744584 Antithrombosis agents |
| 04/28/1998 | US5744448 Human follicle stimulating hormone receptor |
| 04/28/1998 | US5744363 Injecting cell culture medium into isolated tumor and flushing out tumor cells |
| 04/28/1998 | US5744361 Expansion of human hematopoietic progenitor cells in a liquid medium |
| 04/28/1998 | US5744353 Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules |
| 04/28/1998 | US5744347 Excising; detaching from membrane; collecting cells displaying a particular phenotype capable of giving rise to blood cells |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744303 Functional assay for transcriptional regulator genes |
| 04/28/1998 | US5744300 Screening to identify one or more test compounds that can alter gene expression in senescent cells |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744142 Self-assembling recombinant papillomavirus capsid proteins |
| 04/28/1998 | CA2030108C Process for the preparation of genetic vectors for the expression of nerve growth factor in eukaryotic cells |
| 04/28/1998 | CA1339840C Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics |
| 04/23/1998 | WO1998016655A1 Human plasma hyaluronidase |
| 04/23/1998 | WO1998016654A1 Production of a multimeric protein by cell fusion method |
| 04/23/1998 | WO1998016650A1 Enhanced transgene expression in a population of monocot cells employing scaffold attachment regions |
| 04/23/1998 | WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | WO1998016645A2 Compounds and methods for diagnosis of tuberculosis |
| 04/23/1998 | WO1998016644A1 Fibroblast growth factor homologs |
| 04/23/1998 | WO1998016643A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016635A1 Insulin homologs |
| 04/23/1998 | WO1998016630A1 Methods for the generation of primordial germ cells and transgenic animal species |
| 04/23/1998 | WO1998016629A1 Defined systems for epithelial cell culture and use thereof |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016542A1 NOVEL PENICILLIN BINDING PROTEIN FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/23/1998 | WO1998016238A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 04/23/1998 | WO1998016201A1 Therapeutic liposome composition and method |
| 04/23/1998 | WO1998016101A1 Reagent system and kit for detecting hiv infected cells |
| 04/23/1998 | WO1998011228A3 Genetic control of fruit ripening |
| 04/23/1998 | WO1998010076A3 Phospholipase d and dna sequences |
| 04/23/1998 | WO1997041225A3 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
| 04/23/1998 | DE19643314A1 Monoklonale Antikörper gegen das Epitop YPYDVPDYA, Verfahren zu deren Herstellung und Verwendung Monoclonal antibodies against the epitope YPYDVPDYA, to processes for their preparation and use |
| 04/23/1998 | DE19643093A1 Verwendung von FasL oder mit FasL transfizierten CD4+/FasL-/TH1-Zellinien zur Behandlung von TH1/TH2-Krankheiten, Verfahren zur Herstellung von CD4+/FasL+/TH1-Zellinien und Stoffzusammensetzungen von FasL und einem oder mehren Cytokinen sowie dessen Verwendung zur Behandlung von TH1/TH2-Krankheiten Use of FasL or FasL transfected CD4 + / FasL / TH1 cell lines for the treatment of Th1 / Th2 diseases, processes for the production of CD4 + / FasL + / TH1-cell lines and compositions of FasL and to one or more cytokines, as well as its use for the treatment of Th1 / Th2 diseases |
| 04/23/1998 | CA2452540A1 Keratinocyte growth factor-2 products |
| 04/23/1998 | CA2268040A1 Insulin homologs |
| 04/23/1998 | CA2268036A1 Compounds and methods for diagnosis of tuberculosis |
| 04/23/1998 | CA2268008A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | CA2268007A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | CA2267220A1 Methods for the generation of primordial germ cells and transgenic animal species |